Removing the roadblocks to remission. There’s value in that. To tackle rising cancer care costs, we’re working with leading providers and research institutes such as Johns Hopkins Kimmel Cancer Center to establish new best practices in cancer care that have been shown to cost 35% less.1 And that adds up to better outcomes for your employees, and more value for your healthcare dollar. See how we can help improve cancer care and lower cost. Download our free guide at HighmarkCancerCare.com
▶
Jacob Maxim Highmark Cancer Collaborative patient
1. A national study published in the Journal of Oncology Practice found that patients following evidence-based clinical pathways for oncology treatments saw 35% lower costs vs. patients receiving traditional treatment approaches. Highmark Blue Cross Blue Shield is an independent licensee of the Blue Cross and Blue Shield Association.